Funding for this research was provided by:
Instituto de Salud Carlos III (PI17/00083)
Received: 22 September 2021
Accepted: 1 May 2022
First Online: 10 May 2022
: The study protocol was approved by the institutional review committees at Hospital Universitario de Canarias and Hospital Universitario Doctor Negrín, and all subjects provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests. Nevertheless, Professor MA Gonzalez-Gay and Dr. Iván Ferraz-Amaro would like to acknowledge that they received grants/research supports from Abbott, MSD, Jansen, and Roche and received consultation fees from company-sponsored speakers bureaus associated with Abbott, Pfizer, Roche, Sanofi, Sobi, Amgen, Celgene, and MSD.